Despite Advancements in the Treatment Landscape for Type 1 Diabetes, There Is a Significant Need for Innovation

By Tina Gupta, MD

February 28, 2025

Endocrine Society member Tina Gupta, MD, spent many years managing her patients’ type 1 diabetes when she was in a clinical setting. Now that she’s associate medical director on the Type 1 Diabetes Medical Affairs team at Vertex Pharmaceuticals, she’s even more determined to help find solutions to help these patients. As an endocrinologist, my […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today

RELATED ARTICLES

Heroin Adulterated with Diabetes Medication Triggers Life-Threatening Medical Emergencies

Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes

Father’s Tobacco Use May Raise Children’s Diabetes Risk

Health Topics

Patient Populations